Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study
Background: Ductal carcinoma in situ (DCIS) is an in-situ (pre-cancerous) breast malignancy whereby malignant cells are contained within the basement membrane of the breast ducts. Increasing awareness that some low-risk forms of DCIS might remain indolent for many years has led to concern about over...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Breast |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S096097762030179X |
id |
doaj-e6a57fb58ca242c5a6cdb2cd905362a2 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Brooke Nickel Kirsten McCaffery Nehmat Houssami Jesse Jansen Christobel Saunders Andrew Spillane Claudia Rutherford Ann Dixon Alexandra Barratt Kirsty Stuart Geraldine Robertson Jolyn Hersch |
spellingShingle |
Brooke Nickel Kirsten McCaffery Nehmat Houssami Jesse Jansen Christobel Saunders Andrew Spillane Claudia Rutherford Ann Dixon Alexandra Barratt Kirsty Stuart Geraldine Robertson Jolyn Hersch Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study Breast Ductal carcinoma in situ Management Active monitoring Overtreatment Qualitative |
author_facet |
Brooke Nickel Kirsten McCaffery Nehmat Houssami Jesse Jansen Christobel Saunders Andrew Spillane Claudia Rutherford Ann Dixon Alexandra Barratt Kirsty Stuart Geraldine Robertson Jolyn Hersch |
author_sort |
Brooke Nickel |
title |
Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study |
title_short |
Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study |
title_full |
Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study |
title_fullStr |
Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study |
title_full_unstemmed |
Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study |
title_sort |
views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (dcis): qualitative interview study |
publisher |
Elsevier |
series |
Breast |
issn |
1532-3080 |
publishDate |
2020-12-01 |
description |
Background: Ductal carcinoma in situ (DCIS) is an in-situ (pre-cancerous) breast malignancy whereby malignant cells are contained within the basement membrane of the breast ducts. Increasing awareness that some low-risk forms of DCIS might remain indolent for many years has led to concern about overtreatment, with at least 3 clinical trials underway internationally assessing the safety of active monitoring for low-risk DCIS. This study aimed to understand healthcare professionals’ (HCPs) views on the management options for patients with DCIS. Methods: Qualitative study using semi-structured interviews with HCPs involved in the diagnosis and management of DCIS in Australia and New Zealand. Interviews were audio-recorded, transcribed and analysed thematically using Framework Analysis method. Results: Twenty-six HCPs including 10 breast surgeons, 3 breast physicians, 6 radiation oncologists, and 7 breast care nurses participated. There was a strong overall consensus that DCIS requires active treatment. HCPs generally felt uncomfortable recommending active monitoring as a management option for low-risk DCIS as they viewed this as outside current standard care. Overall, HCPs felt that active monitoring was an unproven strategy in need of an evidence base; however, many acknowledged that active monitoring for low-risk DCIS could be appropriate for patients with significant co-morbidities or limited life expectancy. They believed that most patients would opt for surgery wherever possible. Conclusions: This study highlights the important need for robust randomised controlled trial data about active monitoring for women with low-risk DCIS, to provide HCPs with confidence in their management recommendations and decision-making. |
topic |
Ductal carcinoma in situ Management Active monitoring Overtreatment Qualitative |
url |
http://www.sciencedirect.com/science/article/pii/S096097762030179X |
work_keys_str_mv |
AT brookenickel viewsofhealthcareprofessionalsabouttheroleofactivemonitoringinthemanagementofductalcarcinomainsitudcisqualitativeinterviewstudy AT kirstenmccaffery viewsofhealthcareprofessionalsabouttheroleofactivemonitoringinthemanagementofductalcarcinomainsitudcisqualitativeinterviewstudy AT nehmathoussami viewsofhealthcareprofessionalsabouttheroleofactivemonitoringinthemanagementofductalcarcinomainsitudcisqualitativeinterviewstudy AT jessejansen viewsofhealthcareprofessionalsabouttheroleofactivemonitoringinthemanagementofductalcarcinomainsitudcisqualitativeinterviewstudy AT christobelsaunders viewsofhealthcareprofessionalsabouttheroleofactivemonitoringinthemanagementofductalcarcinomainsitudcisqualitativeinterviewstudy AT andrewspillane viewsofhealthcareprofessionalsabouttheroleofactivemonitoringinthemanagementofductalcarcinomainsitudcisqualitativeinterviewstudy AT claudiarutherford viewsofhealthcareprofessionalsabouttheroleofactivemonitoringinthemanagementofductalcarcinomainsitudcisqualitativeinterviewstudy AT anndixon viewsofhealthcareprofessionalsabouttheroleofactivemonitoringinthemanagementofductalcarcinomainsitudcisqualitativeinterviewstudy AT alexandrabarratt viewsofhealthcareprofessionalsabouttheroleofactivemonitoringinthemanagementofductalcarcinomainsitudcisqualitativeinterviewstudy AT kirstystuart viewsofhealthcareprofessionalsabouttheroleofactivemonitoringinthemanagementofductalcarcinomainsitudcisqualitativeinterviewstudy AT geraldinerobertson viewsofhealthcareprofessionalsabouttheroleofactivemonitoringinthemanagementofductalcarcinomainsitudcisqualitativeinterviewstudy AT jolynhersch viewsofhealthcareprofessionalsabouttheroleofactivemonitoringinthemanagementofductalcarcinomainsitudcisqualitativeinterviewstudy |
_version_ |
1724373721044484096 |
spelling |
doaj-e6a57fb58ca242c5a6cdb2cd905362a22020-12-23T04:58:34ZengElsevierBreast1532-30802020-12-015499105Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview studyBrooke Nickel0Kirsten McCaffery1Nehmat Houssami2Jesse Jansen3Christobel Saunders4Andrew Spillane5Claudia Rutherford6Ann Dixon7Alexandra Barratt8Kirsty Stuart9Geraldine Robertson10Jolyn Hersch11Wiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, NSW, Australia; Sydney Health Literacy Lab, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, NSW, AustraliaWiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, NSW, Australia; Sydney Health Literacy Lab, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, NSW, AustraliaWiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, NSW, AustraliaWiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, NSW, Australia; Sydney Health Literacy Lab, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, NSW, Australia; Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the NetherlandsSchool of Medicine, University of Western Australia, Perth, WA, AustraliaThe University of Sydney, Northern Clinical School, St Leonards, NSW, Australia; Mater Hospital, Wollstonecraft, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, AustraliaThe University of Sydney, Faculty of Science, School of Psychology, Sydney, NSW, Australia; The University of Sydney, Faculty Medicine and Health, Sydney Nursing School, Sydney, NSW, AustraliaWiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, NSW, AustraliaWiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, NSW, AustraliaDepartment of Radiation Oncology, Crown Princess Mary Cancer Centre, Westmead, NSW, Australia; Westmead Breast Cancer Institute, Westmead, NSW, Australia; Western Clinical School, The University of Sydney, NSW, AustraliaBreast Cancer Network Australia, VIC, AustraliaWiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, NSW, Australia; Sydney Health Literacy Lab, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, NSW, Australia; Corresponding author. School of Public Health, Level 1, A27 Edward Ford Building, University of Sydney, NSW, 2006, Australia.Background: Ductal carcinoma in situ (DCIS) is an in-situ (pre-cancerous) breast malignancy whereby malignant cells are contained within the basement membrane of the breast ducts. Increasing awareness that some low-risk forms of DCIS might remain indolent for many years has led to concern about overtreatment, with at least 3 clinical trials underway internationally assessing the safety of active monitoring for low-risk DCIS. This study aimed to understand healthcare professionals’ (HCPs) views on the management options for patients with DCIS. Methods: Qualitative study using semi-structured interviews with HCPs involved in the diagnosis and management of DCIS in Australia and New Zealand. Interviews were audio-recorded, transcribed and analysed thematically using Framework Analysis method. Results: Twenty-six HCPs including 10 breast surgeons, 3 breast physicians, 6 radiation oncologists, and 7 breast care nurses participated. There was a strong overall consensus that DCIS requires active treatment. HCPs generally felt uncomfortable recommending active monitoring as a management option for low-risk DCIS as they viewed this as outside current standard care. Overall, HCPs felt that active monitoring was an unproven strategy in need of an evidence base; however, many acknowledged that active monitoring for low-risk DCIS could be appropriate for patients with significant co-morbidities or limited life expectancy. They believed that most patients would opt for surgery wherever possible. Conclusions: This study highlights the important need for robust randomised controlled trial data about active monitoring for women with low-risk DCIS, to provide HCPs with confidence in their management recommendations and decision-making.http://www.sciencedirect.com/science/article/pii/S096097762030179XDuctal carcinoma in situManagementActive monitoringOvertreatmentQualitative |